Home > GCC5694A

molecules of the month

<< Back to February

oral SGLT2 inhibitor - GC Pharma (Green Cross)

GCC5694A

Recent Publication

oral SGLT2 inhibitor

Clinical candidate for diabetes

from literature SGLT2 inhibitor

Bioorganic Med. Chem. Lett.

GC Pharma (Green Cross)

Context. GCC5694A (GC Pharma (Green Cross)) is an oral SGLT2 inhibitor. SGLT2 inhibitors help glycemic control in diabetes by preventing reabsorption of glucose in the kidney. Dapagliflozin was the…

this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.

Join Now

white

GCC5694A

this content is exclusive to Premium members

this content is exclusive to
Premium members